Orange Grove Bio was established with a clear vision: to bridge the gap between promising research programs and the successful development and commercialization of transformative therapies.
Our company is driven by the recognition of the disparity in venture capital investment across different regions of the United States, often resulting in groundbreaking discoveries going unexplored and potentially life-changing treatments failing to reach the patients who need them most.
Based in Cincinnati, we strategically partner with prominent institutions and researchers across the Midwest, Southeast, and Mid-Atlantic regions. By fostering strong partnerships built on a shared commitment to innovation, our aim is to ensure that discoveries from these regions translate into life-changing treatments for patients, unlocking the full potential of the most promising research programs.
Company Details
- Employees
- 28
- Founded
- -
- Address
- Cincinnati, Ohio 45206, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://orangegrovebio.com
- Keywords
- Biotechnology, Oncology, Autoimmune Disease, Inflammatory Disease, Venture Capital, Cystic Fibrosis.
- HQ
- Cincinnati, Ohio
Orange Grove Bio Questions
Orange Grove Bio's website is http://orangegrovebio.com
Orange Grove Bio's LinkedIn profile is https://www.linkedin.com/company/orangegrovebio
Orange Grove Bio has
28 employees.
View email and phone details for 28
employees at Orange Grove Bio.
Orange Grove Bio's industry is
Biotechnology Research
Orange Grove Bio's top competitors are
Graham Partners,
Life Edit Therapeutics,
Northpond Ventures,
Aragen Life Sciences,
Thermo Fisher Scientific,
Cinrx Pharma,
Egateway Capital,
Cti Clinical Trial And Consulting Services,
Jade Biosciences,
Ipinovyx.
Orange Grove Bio's categories are Biotechnology Research
Orange Grove Bio's founding year is 2019
